TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor
(TNF) ligand family that rapidly induces apoptosis in a variety of tra
nsformed cell lines. The human receptor for TRAIL was found to be an u
ndescribed member of the TNF-receptor family (designated death recepto
r-4, DR4) that contains a cytoplasmic ''death domain'' capable of enga
ging the cell suicide apparatus but not the nuclear factor kappa B pat
hway in the system studied. Unlike Fas, TNFR-1, and DR3, DR4 could not
use FADD to transmit the death signal, suggesting the use of distinct
proximal signaling machinery. Thus, the DR4-TRAIL axis defines anothe
r receptor-ligand pair involved in regulating cell suicide and tissue
homeostasis.